Most type 1 diabetes presenting as diabetic ketoacidosis in Vietnamese people is negative for pancreatic islet cell autoantibodies

被引:6
|
作者
Ly, Luong D. [1 ]
Twigg, Stephen M. [2 ,3 ]
Tran, Dung T. [4 ]
Nguyen, Khue T. [1 ]
机构
[1] HCM Univ Med & Pharm, Dept Endocrinol, Ho Chi Minh City, Vietnam
[2] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW, Australia
[4] Pham Ngoc Thach Univ Med, Dept Internal Med, Ho Chi Minh City, Vietnam
关键词
Type; 1; Ketoacidosis; Autoantibodies; POPULATION;
D O I
10.1016/j.diabres.2012.01.034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Eighteen Vietnamese type 1 diabetic patients presented with ketoacidosis were serially recruited from three tertiary cares. They had mean age (+/-SD) 23.5 +/- 4.1 years, median of blood glucose [interquartile range] 28.2 [24.3-31.3] mmol/L, pH 7.255 [7.232-7.285], C-peptide 0.265 [0.098-0.472] nmol/L. 61% were negative for both anti-GAD and ICA tests. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:E63 / E65
页数:3
相关论文
共 50 条
  • [41] Effect of covid-19 infection on diabetic ketoacidosis (DKA) in people with type 1 and type 2 diabetes
    Rengarajan, L.
    Kempegowda, P.
    Melson, E.
    Johnson, A.
    Wallett, L.
    Zhou, D.
    Juszczak, A.
    Karamat, M. A.
    Narendran, P.
    Bellary, S.
    DIABETIC MEDICINE, 2021, 38
  • [42] Diabetic Ketoacidosis in Type 2 vs. Type 1 Diabetes
    Miles, John M.
    Accurso, Anthony D.
    Isautier, Jennifer
    Marquez, Alberto
    Wilson, Gregory A.
    Kudva, Yogish C.
    DIABETES, 2016, 65 : A405 - A405
  • [43] Number of islet autoantibodies present in newly diagnosed type 1 diabetes children born to non-diabetic mothers is affected by islet autoantibodies present at birth
    Elfving, Maria
    Lindberg, Bengt
    Lynch, Kristian
    Mansson, Majvi
    Sundkvist, Goran
    Lernmark, Ake
    Ivarsson, Sten A.
    PEDIATRIC DIABETES, 2008, 9 (02) : 127 - 134
  • [44] DIABETIC KETOACIDOSIS IN TYPE 2 VS. TYPE 1 DIABETES
    Miles, J. M.
    Accurso, A.
    Isautier, J.
    Marquez, A. E.
    Wilson, G.
    Herrmann, K.
    Kudva, Y.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (01) : 240 - 240
  • [45] Slowly progressing type 1 diabetes: Persistence of islet cell autoantibodies is related to glibenclamide treatment
    Cabrera-Rode, E
    Perich, P
    Diaz-Horta, O
    Tiberti, C
    Molina, G
    Arranz, C
    Martin, JM
    Licea, M
    De Leiva, A
    Puig-Domingo, M
    Dimario, U
    AUTOIMMUNITY, 2002, 35 (07) : 469 - 474
  • [46] PREVALENCE OF ISLET-CELL AND THYROGASTRIC AUTOANTIBODIES IN SUDANESE PATIENTS WITH TYPE-1 DIABETES
    MAGZOUB, MMA
    ABDELHAMEED, AA
    BOTTAZZO, GF
    DIABETIC MEDICINE, 1994, 11 (02) : 188 - 192
  • [47] AUTOANTIBODIES PRESENT AT ONSET OF TYPE-1 DIABETES RECOGNIZE MULTIPLE ISLET CELL ANTIGENS
    KAROUNOS, DG
    NELL, LJ
    THOMAS, JW
    AUTOIMMUNITY, 1990, 6 (1-2) : 79 - 91
  • [48] Diabetic Ketoacidosis and Memory Dysfunction in Children with Type 1 Diabetes
    Ghetti, Simona
    Lee, Joshua K.
    Sims, Clare E.
    DeMaster, Dana M.
    Glaser, Nicole S.
    JOURNAL OF PEDIATRICS, 2010, 156 (01): : 109 - 114
  • [49] Diabetic ketoacidosis at the onset of type 1 diabetes: Frequency and interfering
    Rodacki, Melanie
    Dantas, Joana
    Nabuco, Aline
    Barone, Bianca
    Mac Dowell, Renata
    Bravo, Michelle
    Perricelli, Paula
    Brum, Julia
    Ornellas, Phelipe
    Belem, Luciana
    Oliveira, Marcus M.
    Szundy, Renata
    Luescher, Jorge
    Kupfer, Rosane
    Vangelotti, Andrea M.
    Zajdenverg, Lenita
    Milech, Adolpho
    Oliveira, Jose E.
    DIABETES, 2007, 56 : A240 - A241
  • [50] Tryptophan, kynurenine pathway, and diabetic ketoacidosis in type 1 diabetes
    Hoffman, William H.
    Whelan, Stephen A.
    Lee, Norman
    PLOS ONE, 2021, 16 (07):